Hasil Pencarian - Zaima Mazorra

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    GM3 ganglioside: a novel target for the therapy against melanoma

    GM3 ganglioside: a novel target for the therapy against melanoma oleh Zaima Mazorra, Cirse Mesa, Luis E Fernández

    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck

    Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck oleh Tania Crombet Ramos, Braulio Mestre Fernández, Zaima Mazorra Herrera, Normando E. Iznaga Escobar

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Validación del ultramicrométodo inmunocitoquímico (UMICIQ) para el inmunofenotipaje de la leucemia linfoide aguda pediátrica Validation of immunocytochemical ultramicromethod (UMICIQ) for immunophenotyping of pediatric acute lymphoid leukemia

    Validación del ultramicrométodo inmunocitoquímico (UMICIQ) para el inmunofenotipaje de la leucemia linfoide aguda pediátrica Validation of immunocytochemical ultramicromethod (UMIC... oleh Vianed Marsán-Suárez, Lázaro del Valle-Pérez, Berta B Socarrás-Ferrer, Miriam Sánchez-Segura, Consuelo Macías-Abraham, Zaima Mazorra-Hererra, Rosa M Lam-Díaz

    Diterbitkan 2012-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule

    Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule oleh Xitlally Popa, Beatriz García, Karla P. Fuentes, Vivian Huerta, Karen Alvarez, Carmen E. Viada, Elia Neninger, Pedro C. Rodríguez, Zuyen González, Amnely González, Tania Crombet, Zaima Mazorra

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

    An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients oleh Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, Carlos Hidalgo, Geydi Lorenzo, Meylan Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Reposicionamiento del anticuerpo monoclonal humanizado anti-CD6 itolizumab en el tratamiento de pacientes con COVID-19

    Reposicionamiento del anticuerpo monoclonal humanizado anti-CD6 itolizumab en el tratamiento de pacientes con COVID-19 oleh Tania Crombet Ramos, Mayra Ramos Suzarte, Danay Saavedra Hernández, Kalet León Monzón, Julio Betancourt Cervantes, Lázaro Filgueira Morilla, Carlos J. Hidalgo Mesa, Yayquier Díaz Morales, Zaima Mazorra Herrera, Patricia Lorenzo Luaces, Carmen Valenzuela Silva, Geydi Lorenzo Monteagudo, Meyán Cepeda Portales, Armando Caballero López

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial

    Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Tr... oleh Iraida Caballero, Lazaro E. Aira, Anabel Lavastida, Xitlally Popa, Javier Rivero, Joaquín González, Mónica Mesa, Narjara González, Kelly Coba, Patricia Lorenzo-Luaces, Barbara Wilkinson, Yuliannis Santiesteban, Yanela Santiesteban, Mayelin Troche, Eduardo Suarez, Tania Crombet, Belinda Sánchez, Angel Casacó, Amparo Macías, Zaima Mazorra

    Diterbitkan 2017-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients

    Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients oleh Zaima Mazorra, Anabel Lavastida, Fernando Concha-Benavente, Anet Valdés, Raghvendra M. Srivastava, Tatiana M. García-Bates, Esperanza Hechavarría, Zuyen González, Amnely González, Martha Lugiollo, Iván Cuevas, Carlos Frómeta, Braulio F. Mestre, Maria C. Barroso, Tania Crombet, Robert L. Ferris, Robert L. Ferris, Robert L. Ferris

    Diterbitkan 2017-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Assessment of non-classical lymphocyte populations in patients with advanced lung cancer treated with Biomodulina T following platinum-based chemotherapy

    Assessment of non-classical lymphocyte populations in patients with advanced lung cancer treated with Biomodulina T following platinum-based chemotherapy oleh Gisela María Suárez, Mauricio Catalá, Yadira Peña, Susana Portela, Ana Laura Añé-Kourí, Amnely González, Patricia Lorenzo-Luaces, Manuel Díaz, María de los A. Molina, Karla Pereira, Jenysbel de la C. Hernández, Mary Carmen Reyes, Nuris Ledón, Zaima Mazorra, Tania Crombet, Agustin Lage, Antonio Bencomo-Hernandez, Danay Saavedra

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy

    Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy oleh Gisela María Suárez, Mauricio Catalá, Yadira Peña, Susana Portela, Ana Laura Añé-Kourí, Amnely González, Patricia Lorenzo-Luaces, Manuel Díaz, María de los A. Molina, Karla Pereira, Jenysbel de la C. Hernández, Raúl Ramos, Raúl Ramos, Mary Carmen Reyes, Nuris Ledón, Zaima Mazorra, Tania Crombet, Agustin Lage, Danay Saavedra

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

    Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC oleh Rachel Evans, Kelvin Lee, Paul K. Wallace, Mary Reid, Jason Muhitch, Askia Dozier, Circe Mesa, Patricia L. Luaces, Orestes Santos-Morales, Adrienne Groman, Carlos Cedeno, Aileen Cinquino, Daniel T. Fisher, Igor Puzanov, Mateusz Opyrchal, Christos Fountzilas, Tong Dai, Marc Ernstoff, Kristopher Attwood, Alan Hutson, Candace Johnson, Zaima Mazorra, Danay Saavedra, Kalet Leon, Agustin Lage, Tania Crombet, Grace K. Dy

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: